Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Boeing
BA
|
+$1.54B |
| 2 |
D.R. Horton
DHI
|
+$1.12B |
| 3 |
NVIDIA
NVDA
|
+$967M |
| 4 |
Netflix
NFLX
|
+$943M |
| 5 |
GE Aerospace
GE
|
+$924M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 2 |
Apple
AAPL
|
+$1.54B |
| 3 |
Amazon
AMZN
|
+$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.43B |
| 5 |
Microsoft
MSFT
|
+$1.22B |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 17.33% |
| 3 | Industrials | 12.85% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Centene
CNC
$16B
| $228M | 0.07% |
2,782,295
-47,438
| -2% | -$3.89M |
|
202
Merck
MRK
$202B
| $226M | 0.07% |
2,037,894
+977
| +0% | +$108K |
|
|
SRCL
203
DELISTED
Stericycle Inc
SRCL
| $225M | 0.07% |
4,514,922
+75,308
| +2% | +$3.76M |
|
204
McCormick & Company Non-Voting
MKC
$17.7B
| $225M | 0.07% |
2,713,521
-371
| -0% | -$30.8K |
|
205
MongoDB
MDB
$27.2B
| $220M | 0.07% |
1,116,974
-782,252
| -41% | -$154M |
|
206
Steel Dynamics
STLD
$19.4B
| $217M | 0.07% |
2,222,330
+200,139
| +10% | +$19.6M |
|
207
Agilon Health
AGL
$460M
| $217M | 0.07% |
13,428,559
-560,028
| -4% | -$9.04M |
|
208
Integra LifeSciences
IART
$1.17B
| $214M | 0.06% |
3,823,726
+702,779
| +23% | +$39.4M |
|
209
Amphenol
APH
$146B
| $214M | 0.06% |
5,625,634
-772
| -0% | -$29.4K |
|
210
Pfizer
PFE
$136B
| $213M | 0.06% |
4,158,180
+679,981
| +20% | +$34.8M |
|
211
Cullen/Frost Bankers
CFR
$8.2B
| $211M | 0.06% |
1,579,942
-662,064
| -30% | -$88.5M |
|
212
Coca-Cola
KO
$285B
| $209M | 0.06% |
3,277,791
-5,176,552
| -61% | -$329M |
|
213
Cisco
CSCO
$265B
| $201M | 0.06% |
4,220,333
-659
| -0% | -$31.4K |
|
214
Charles Schwab
SCHW
$167B
| $200M | 0.06% |
2,401,294
-2,134,014
| -47% | -$178M |
|
215
Alnylam Pharmaceuticals
ALNY
$60.4B
| $198M | 0.06% |
+832,117
| New | +$198M |
|
|
AZEK
216
DELISTED
The AZEK Co
AZEK
| $197M | 0.06% |
9,712,794
+7,688,535
| +380% | +$156M |
|
217
DT Midstream
DTM
$10.8B
| $196M | 0.06% |
3,542,640
-729,573
| -17% | -$40.3M |
|
218
CONMED
CNMD
$1.6B
| $194M | 0.06% |
2,192,394
+452,982
| +26% | +$40.2M |
|
219
S&P Global
SPGI
$166B
| $193M | 0.06% |
575,673
-882,984
| -61% | -$296M |
|
220
Thor Industries
THO
$5.54B
| $191M | 0.06% |
2,526,116
-57,984
| -2% | -$4.38M |
|
221
Euronet Worldwide
EEFT
$3.55B
| $190M | 0.06% |
2,017,265
+424,916
| +27% | +$40.1M |
|
222
Paycom
PAYC
$12.3B
| $189M | 0.06% |
608,805
-319,905
| -34% | -$99.3M |
|
223
Light & Wonder
LNW
$7.59B
| $188M | 0.06% |
3,203,862
+423,200
| +15% | +$24.8M |
|
224
Helen of Troy
HELE
$545M
| $182M | 0.06% |
1,645,219
+304,150
| +23% | +$33.7M |
|
225
Icon
ICLR
$13.3B
| $181M | 0.05% |
929,761
+37,268
| +4% | +$7.24M |
|